Infliximab in inflammatory bowel disease: attention to adverse events

Date
2014
Author
Demir, K.
Besisik, F.
Aydogan, T.
Kaymakoglu, S.
Baran, B.
Uyanikoglu, A.
Ermis, F.
Akyuz, F.
Pinarbasi, B.
Metadata
Show full item record
Abstract
OBJECTIVE: To assess the efficacy and adverse effects of infliximab in patients with Crohn's disease and ulcerative colitis who are resistant to conventional therapy or having fistulising type Crohn's disease.
URI
http://hdl.handle.net/20.500.12627/39053
Collections